1-Ethyl-1H-imidazole-4-carboxamide

Catalog No.: 
ACSTGZ302
CAS No.: 
129993-48-2
Molecular Formula: 
C6H9N3O
Molecular Weight: 
139.16
1-Ethyl-1H-imidazole-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$68.00In stockInquiry
250mg97%$114.00In stockInquiry
1g97%$307.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Ethyl-1H-imidazole-4-carboxamide
IUPAC Name1-ethyl-1H-imidazole-4-carboxamide
MDL No.MFCD18808644
Molecular FormulaC6H9N3O
Molecular Weight139.16
SMILESCCN1C=NC(C(N)=O)=C1
InChI KeyCHOASOWXPVAAMI-UHFFFAOYSA-N
Synonym1H-Imidazole-4-carboxamide,1-ethyl-(9CI)
CAS No.129993-48-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACSTGZ302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACSTGZ302 route product structure diagram
    ACSTGZ302129993-48-2In Stock
Inquiry

2. ACSTGZ302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACSTGZ302 route product structure diagram
    ACSTGZ302129993-48-2In Stock
Inquiry

3. ACSTGZ302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVMOS368 route compound structure diagram
    ACVMOS36826832-08-6In Stock
  4. Then
  5. ACSTGZ302 route product structure diagram
    ACSTGZ302129993-48-2In Stock
Inquiry

Comments (0)